This site is intended for Healthcare Professionals only.

Paul Kiran

Exclusive Content

Exclusive: BGMA chief executive on how CPTPP accession will affect UK medicine manufacturers

CPTPP membership could attract more suppliers to the UK...

Community pharmacy ‘overlooked’ during pandemic, NPA tells Covid-19 Inquiry

The NPA asked the Inquiry to consider the resilience...

Work pressures contributing to rise in suicidal thoughts among nurses – RCN report reveals

Workload, bullying and harassment, and a lack of work-life...

Pharmacists can use original pack dispensing for NHS prescriptions from January 2025

Community Pharmacy England has advised pharmacists to use professional...

Layla Moran elected Chair of Health and Social Care Committee

The Liberal Democrat MP emphasises the importance of finding...

Pharmacist Support launches dual-focused fundraising campaign

As Remember a Charity Week begins, Pharmacist Support is...

NPA raises question of accountability over authorising of pharmacy technicians

The government’s formal consultation on pharmacy supervision, which closes today (29 February), leaves important questions unanswered, the National Pharmacy Association (NPA) has warned. The Department...

Britain seeks ‘urgent reversal’ of fall in childhood vaccination rates

The government will on Thursday launch a drive to boost childhood vaccination rates, health authorities said, seeking an "urgent reversal" to a fall in...

Health and care worker visas almost doubled in 2023

Britain almost doubled the number of visas awarded to foreign migrants coming to work in the health and care sector last year, government data...

Pfizer says its RSV shot is protective through a second year

Pfizer on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the illness...

Novavax sees 2024 sales flat to lower, aims to pick up Covid vaccine market share

Covid-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as it works to improve its commercial...

Drugmaker Sandoz to pay $265m to settle US pricing case

Swiss generic drugmaker Sandoz said on Thursday that it would pay $265 million (£209m) to settle a pricing antitrust case in the US. Under the...